These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 26521766)

  • 1. Cost Accounting as a Tool for Increasing Cost Transparency in Selective Hepatic Transarterial Chemoembolization.
    Ahmed O; Patel M; Ward T; Sze DY; Telischak K; Kothary N; Hofmann LV
    J Vasc Interv Radiol; 2015 Dec; 26(12):1820-6.e1. PubMed ID: 26521766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calculation of operating expenses for conventional transarterial chemoembolization in an academic medical center: a step toward defining the value of transarterial chemoembolization.
    Beheshti MV; Meek J
    J Vasc Interv Radiol; 2014 Apr; 25(4):567-74. PubMed ID: 24462006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost effectiveness of radioembolization compared with conventional transarterial chemoembolization for treatment of hepatocellular carcinoma.
    Rostambeigi N; Dekarske AS; Austin EE; Golzarian J; Cressman EN
    J Vasc Interv Radiol; 2014 Jul; 25(7):1075-84. PubMed ID: 24861664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventional radiologic treatment of hepatocellular carcinoma-a cost analysis from the payer perspective.
    Ray CE; Battaglia C; Libby AM; Prochazka A; Xu S; Funaki B
    J Vasc Interv Radiol; 2012 Mar; 23(3):306-14. PubMed ID: 22277271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and economic impact of drug eluting beads in transarterial chemoembolization for hepatocellular carcinoma.
    Vadot L; Boulin M; Guiu B; Aho LS; Vourc'h M; Musat A; Hillon P; Lepage C; Guignard MH; Fagnoni P
    J Clin Pharm Ther; 2015 Feb; 40(1):83-90. PubMed ID: 25413186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct costs of care for hepatocellular carcinoma in patients with hepatitis C cirrhosis.
    Tapper EB; Catana AM; Sethi N; Mansuri D; Sethi S; Vong A; Afdhal NH
    Cancer; 2016 Mar; 122(6):852-8. PubMed ID: 26716758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medico-economic study of the management of hepatocellular carcinoma by chemo-embolization.
    Clouet J; Audureau D; Lefranc B; Maillard N; Guilé R; Frampas E; Perret C; Grimandi G
    Diagn Interv Imaging; 2014 Apr; 95(4):427-34. PubMed ID: 24231346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transarterial chemoembolization for primary liver malignancies and colorectal liver metastasis.
    Miura JT; Gamblin TC
    Surg Oncol Clin N Am; 2015 Jan; 24(1):149-66. PubMed ID: 25444473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment patterns and direct medical costs among patients with advanced hepatocellular carcinoma.
    Aly A; Malangone-Monaco E; Noxon V; Henriques C; Benavente F; Kim A
    Curr Med Res Opin; 2020 Nov; 36(11):1813-1823. PubMed ID: 32969741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of preoperative transarterial chemoembolization of resectable hepatocellular carcinoma on clinical and economic outcomes.
    Lee KT; Lu YW; Wang SN; Chen HY; Chuang SC; Chang WT; Shi HY; Ker CG; Chiu HC
    J Surg Oncol; 2009 May; 99(6):343-50. PubMed ID: 19226530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment and Cost of Hepatocellular Carcinoma: A Population-Based Cohort Study in Taiwan.
    Nguang SH; Wu CK; Liang CM; Tai WC; Yang SC; Ku MK; Yuan LT; Wang JW; Tseng KL; Hung TH; Hsu PI; Wu DC; Chuah SK; Hsu CN
    Int J Environ Res Public Health; 2018 Nov; 15(12):. PubMed ID: 30486324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transarterial chemoembolization with additional cisplatin infusion for hepatocellular carcinoma invading the hepatic vein.
    Kim HC; Lee JH; Chung JW; Kang B; Yoon JH; Kim YJ; Lee HS; Jae HJ; Park JH
    J Vasc Interv Radiol; 2013 Feb; 24(2):274-83. PubMed ID: 23369561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Result and cost of hepatic chemoembolisation with drug eluting beads in 21 patients.
    Vadot L; Boulin M; Malbranche C; Guiu B; Aho S; Musat A; Pernot C; Guignard MH; Hillon P; Fagnoni P
    Diagn Interv Imaging; 2013 Jan; 94(1):53-9. PubMed ID: 23146417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response Evaluation Criteria in Solid Tumors (RECIST) criteria are superior to European Association for Study of the Liver (EASL) criteria at 1 month follow-up for predicting long-term survival in patients treated with transarterial chemoembolization before liver transplantation for hepatocellular cancer.
    Shuster A; Huynh TJ; Rajan DK; Marquez MA; Grant DR; Huynh DC; Jaskolka JD
    J Vasc Interv Radiol; 2013 Jun; 24(6):805-12. PubMed ID: 23562641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transarterial chemoembolization treatment: association between multiple treatments, cumulative expenditures, and survival.
    Breunig IM; Shaya FT; Hanna N; Seal B; Chirikov VV; Daniel Mullins C
    Value Health; 2013; 16(5):760-8. PubMed ID: 23947969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transarterial chemoembolization (TACE) for unresectable hepatocellular carcinoma in cirrhotics: functional hepatic reserve and survival.
    Grieco A; Marcoccia S; Miele L; Marmiroli L; Caminiti G; Ragazzoni E; Cotroneo AR; Cefaro GA; Rapaccini GL; Gasbarrini G
    Hepatogastroenterology; 2003; 50(49):207-12. PubMed ID: 12630024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of treatments involving radioembolization in intermediate-stage hepatocellular carcinoma.
    Rognoni C; Ciani O; Sommariva S; Tarricone R
    J Comp Eff Res; 2018 Mar; 7(3):209-221. PubMed ID: 29231047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Image fusion of preprocedural CTA with real-time fluoroscopy to guide proper hepatic artery catheterization during transarterial chemoembolization of hepatocellular carcinoma: a feasibility study.
    Bargellini I; Turini F; Bozzi E; Lauretti D; Cicorelli A; Lunardi A; Cioni R; Bartolozzi C
    Cardiovasc Intervent Radiol; 2013 Apr; 36(2):526-30. PubMed ID: 23070106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome.
    Kim IS; Lim YS; Lee HC; Suh DJ; Lee YJ; Lee SG
    Aliment Pharmacol Ther; 2008 Feb; 27(4):338-45. PubMed ID: 18047564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transarterial chemoembolization for hepatocellular carcinoma: An old method, now flavor of the day.
    Boulin M; Delhom E; Pierredon-Foulongne MA; Cercueil JP; Guiu B
    Diagn Interv Imaging; 2015 Jun; 96(6):607-15. PubMed ID: 25998996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.